Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 2000; Volume 57,Issue 5

MINIREVIEW

  • You have access
    Inhibition of HIV Infection by Bicyclams, Highly Potent and Specific CXCR4 Antagonists
    Erik De Clercq
    Molecular Pharmacology May 2000, 57 (5) 833-839;

Articles

  • You have access
    The Guanine Nucleotide Exchange Factor RasGRP Is a High -Affinity Target for Diacylglycerol and Phorbol Esters
    Patricia S. Lorenzo, Maryam Beheshti, George R. Pettit, James C. Stone and Peter M. Blumberg
    Molecular Pharmacology May 2000, 57 (5) 840-846;
  • You have access
    Regulation of Recombinant γ-Aminobutyric Acid (GABA)A and GABAC Receptors by Protein Kinase C
    Natalia Filippova, Anna Sedelnikova, Yinong Zong, Henry Fortinberry and David S. Weiss
    Molecular Pharmacology May 2000, 57 (5) 847-856;
  • You have access
    Up-Regulation of Airway Smooth Muscle Histamine H1Receptor mRNA, Protein, and Function by β2-Adrenoceptor Activation
    Judith C. W. Mak, Ad F. Roffel, Toshio Katsunuma, Carolina R. S. Elzinga, Johan Zaagsma and Peter J. Barnes
    Molecular Pharmacology May 2000, 57 (5) 857-864;
  • You have access
    Stimulatory Effects of δ-Hexachlorocyclohexane on Ca2+-Activated K+ Currents in GH3Lactotrophs
    Sheng-Nan Wu, Hui-Fang Li and Hung-Ting Chiang
    Molecular Pharmacology May 2000, 57 (5) 865-874;
  • You have access
    Mutating the Highly Conserved Second Membrane-Spanning Region 9′ Leucine Residue in the α1 or β1 Subunit Produces Subunit-Specific Changes in the Function of Human α1β1 γ-Aminobutyric AcidAReceptors
    Julie E. Dalziel, Graeme B. Cox, Peter W. Gage and Bryndis Birnir
    Molecular Pharmacology May 2000, 57 (5) 875-882;
  • You have access
    Importance of Valine at Position 152 for the Substrate Transport and 2β-Carbomethoxy-3β-(4-fluorophenyl)tropane Binding of Dopamine Transporter
    Sang-Hun Lee, Mi-yoon Chang, Ki-Hwan Lee, Byung Sup Park, Young-Seek Lee, Hemin R. Chin and Yong-Sung Lee
    Molecular Pharmacology May 2000, 57 (5) 883-889;
  • You have access
    The Effect of Mutations in the DRY Motif on the Constitutive Activity and Structural Instability of the Histamine H2Receptor
    Astrid E. Alewijnse, Henk Timmerman, Edwin H. Jacobs, Martine J. Smit, Edwin Roovers, Susanna Cotecchia and Rob Leurs
    Molecular Pharmacology May 2000, 57 (5) 890-898;
  • You have access
    Mechanism-Based Inactivation of Human Dihydropyrimidine Dehydrogenase by (E)-5-(2-Bromovinyl)uracil in the Presence of NADPH
    Takahito Nishiyama, Kenichiro Ogura, Haruhiro Okuda, Kazuma Suda, Atsushi Kato and Tadashi Watabe
    Molecular Pharmacology May 2000, 57 (5) 899-905;
  • You have access
    The Neuroprotective Agent Riluzole Activates the Two P Domain K+ Channels TREK-1 and TRAAK
    Fabrice Duprat, Florian Lesage, Amanda J. Patel, Michel Fink, Georges Romey and Michel Lazdunski
    Molecular Pharmacology May 2000, 57 (5) 906-912;
  • You have access
    125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain
    Paul Whiteaker, J. Michael McIntosh, Siqin Luo, Allan C. Collins and Michael J. Marks
    Molecular Pharmacology May 2000, 57 (5) 913-925;
  • You have access
    ATP, an Agonist at the Rat P2Y4 Receptor, Is an Antagonist at the Human P2Y4 Receptor
    Charles Kennedy, Ai-Dong Qi, Christopher L. Herold, T. Kendall Harden and Robert A. Nicholas
    Molecular Pharmacology May 2000, 57 (5) 926-931;
  • You have access
    Identification of Benzodiazepine Binding Site Residues in the γ2 Subunit of the γ-Aminobutyric AcidA Receptor
    Amy M. Kucken, David A. Wagner, Peter R. Ward, Jeremy A. Teissére, Andrew J. Boileau and Cynthia Czajkowski
    Molecular Pharmacology May 2000, 57 (5) 932-939;
  • You have access
    Octamer Transcription Factor-1 Enhances Hepatic Nuclear Factor-1α-Mediated Activation of the Human UDP Glucuronosyltransferase 2B7 Promoter
    Yuji Ishii, Antony J. Hansen and Peter I. Mackenzie
    Molecular Pharmacology May 2000, 57 (5) 940-947;
  • You have access
    The Mechanism of Phosphorylation of Anti-HIV D4T by Nucleoside Diphosphate Kinase
    Benoit Schneider, Ricardo Biondi, Robert Sarfati, Fabrice Agou, Catherine Guerreiro, Dominique Deville-Bonne and Michel Veron
    Molecular Pharmacology May 2000, 57 (5) 948-953;
  • You have access
    Mutational Analysis of Trp-229 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) Identifies This Amino Acid Residue as a Prime Target for the Rational Design of New Non-Nucleoside RT Inhibitors
    Heidi Pelemans, Robert Esnouf, Erik De Clercq and Jan Balzarini
    Molecular Pharmacology May 2000, 57 (5) 954-960;
  • You have access
    Activation of Signal Transducers and Activators of Transcription by α1A-Adrenergic Receptor Stimulation in PC12 Cells
    Hongying Zhong, T. J. Murphy and Kenneth P. Minneman
    Molecular Pharmacology May 2000, 57 (5) 961-967;
  • You have access
    [3H]MRE 3008F20: A Novel Antagonist Radioligand for the Pharmacological and Biochemical Characterization of Human A3 Adenosine Receptors
    Katia Varani, Stefania Merighi, Stefania Gessi, Karl-Norbert Klotz, Edward Leung, Pier Giovanni Baraldi, Barbara Cacciari, Romeo Romagnoli, Giampiero Spalluto and Pier Andrea Borea
    Molecular Pharmacology May 2000, 57 (5) 968-975;
  • You have access
    Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
    Toshimasa Ishizaki, Masayoshi Uehata, Ichiro Tamechika, Jeongsin Keel, Kimiko Nonomura, Midori Maekawa and Shuh Narumiya
    Molecular Pharmacology May 2000, 57 (5) 976-983;
  • You have access
    Role for Early Growth Response-1 Protein in α1-Adrenergic Stimulation of Fibroblast Growth Factor-2 Promoter Activity in Cardiac Myocytes
    Yan Jin, Farah Sheikh, Karen A. Detillieux and Peter A. Cattini
    Molecular Pharmacology May 2000, 57 (5) 984-990;
  • You have access
    Analysis of a Mutation in Phosphodiesterase Type 4 that Alters Both Inhibitor Activity and Nucleotide Selectivity
    Sarah B. Herman, Dawn M. Juilfs, Eric B. Fauman, Paul Juneau and Joseph P. Menetski
    Molecular Pharmacology May 2000, 57 (5) 991-999;
  • You have access
    Activation of Cannabinoid Receptors in Rat Brain by WIN 55212-2 Produces Coupling to Multiple G Protein α-Subunits with Different Potencies
    Paul L. Prather, Nancy A. Martin, Christopher S. Breivogel and Steven R. Childers
    Molecular Pharmacology May 2000, 57 (5) 1000-1010;
  • You have access
    Increased CYP2J Expression and Epoxyeicosatrienoic Acid Formation in Spontaneously Hypertensive Rat Kidney
    Zhigang Yu, Linn M. Huse, Peter Adler, LeRae Graham, Jixiang Ma, Darryl C. Zeldin and Deanna L. Kroetz
    Molecular Pharmacology May 2000, 57 (5) 1011-1020;
  • You have access
    Inhibition of Aquaporin-1 Water Permeability by Tetraethylammonium: Involvement of the Loop E Pore Region
    Heddwen L. Brooks, John W. Regan and Andrea J. Yool
    Molecular Pharmacology May 2000, 57 (5) 1021-1026;
  • You have access
    Lysophosphatidic Acid Modulates α1b-Adrenoceptor Phosphorylation and Function: Roles of Gi and Phosphoinositide 3-Kinase
    Patricia Casas-González, José Vázquez-Prado and J. Adolfo García-Sáinz
    Molecular Pharmacology May 2000, 57 (5) 1027-1033;
  • You have access
    Human 5-Hydroxytryptamine5A Receptors Activate Coexpressed Gi and Go Proteins inSpodoptera frugiperda 9 Cells
    Bart J. B. Francken, Katty Josson, Peter Lijnen, Mirek Jurzak, Walter H. M. L. Luyten and Josée E. Leysen
    Molecular Pharmacology May 2000, 57 (5) 1034-1044;
  • You have access
    Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide
    Waldemar Gonsiorek, Charles Lunn, Xuedong Fan, Satwant Narula, Daniel Lundell and R. William Hipkin
    Molecular Pharmacology May 2000, 57 (5) 1045-1050;
  • You have access
    Excision of β-d- and β-l-Nucleotide Analogs from DNA by the Human Cytosolic 3′-to-5′ Exonuclease
    Helene Pelicano, Marina Kukhanova and Yung-Chi Cheng
    Molecular Pharmacology May 2000, 57 (5) 1051-1055;
  • You have access
    Altered Cell Cycle Control at the G2/M Phases in Aryl Hydrocarbon Receptor-Null Embryo Fibroblast
    Guillermo Elizondo, Pedro Fernandez-Salguero, M. Saeed Sheikh, Geum-Yi Kim, Albert J. Fornace, Kyung S. Lee and Frank J. Gonzalez
    Molecular Pharmacology May 2000, 57 (5) 1056-1063;
  • You have access
    Involvement of Regions in Domain I in the Opioid Receptor Sensitivity of α1B Ca2+ Channels
    Arthur A. Simen and Richard J. Miller
    Molecular Pharmacology May 2000, 57 (5) 1064-1074;

Accelerated Communication

  • You have access
    Selective Enhancement of β-Adrenergic Receptor Signaling by Overexpression of Adenylyl Cyclase Type 6: Colocalization of Receptor and Adenylyl Cyclase in Caveolae of Cardiac Myocytes
    Rennolds S. Ostrom, Jonathan D. Violin, Scott Coleman and Paul A. Insel
    Molecular Pharmacology May 2000, 57 (5) 1075-1079;
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 57 (5)
Molecular Pharmacology
Vol. 57, Issue 5
1 May 2000
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • MINIREVIEW
  • Articles
  • Accelerated Communication
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics